Purpose Of Review: To allow readers to fully appreciate the uncertainties with this novel yet invasive approach to stroke prevention.
Recent Findings: Percutaneous left atrial (LA) appendage occlusion has emerged as potential nonpharmacologic means to prevent stroke and systemic embolism in patients with atrial fibrillation. Yet the evidence underpinning this new technology is not definitive.
Summary: In this review, we consider the internal and external validity of the regulatory trials, pathophysiologic basis for LA appendage occlusion and clinical tradeoffs of the procedure.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1097/HCO.0000000000000698 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!